…
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 91.00M | 207.80M | 236.30M | 780.00M | 411.50M |
| Minority interest | - | -1.10M | -1.10M | -4.00M | -2.00M |
| Net income | 62.00M | 158.50M | 171.00M | 649.30M | 320.80M |
| Selling general administrative | - | 427.20M | 405.30M | 439.10M | 407.70M |
| Selling and marketing expenses | - | 79.20M | 77.20M | 101.80M | 93.00M |
| Gross profit | 608.70M | 733.90M | 730.00M | 985.60M | 938.90M |
| Reconciled depreciation | - | 135.80M | 126.20M | 120.70M | 113.30M |
| Ebit | 243.70M | 238.70M | 262.30M | 444.70M | 438.20M |
| Ebitda | 380.70M | 374.50M | 388.50M | 554.50M | 546.60M |
| Depreciation and amortization | 137.00M | 135.80M | 126.20M | 109.80M | 108.40M |
| Operating income | 243.70M | 227.50M | 247.50M | 444.70M | 438.20M |
| Other operating expenses | 1455.70M | 1400.60M | 1447.00M | 1608.50M | 1457.80M |
| Interest expense | 28.30M | 30.90M | 25.90M | 8.30M | 25.70M |
| Tax provision | - | 48.20M | 64.20M | 126.70M | 88.70M |
| Interest income | - | 11.30M | 14.80M | 5.10M | 1.50M |
| Net interest income | - | -19.70M | -11.20M | -20.70M | -24.20M |
| Income tax expense | 26.30M | 48.20M | 64.20M | 126.70M | 88.70M |
| Total revenue | 1699.40M | 1628.10M | 1694.50M | 2089.30M | 1889.60M |
| Total operating expenses | 365.00M | 506.40M | 482.50M | 504.80M | 507.10M |
| Cost of revenue | 1090.70M | 894.20M | 964.50M | 1103.70M | 950.70M |
| Total other income expense net | -152.70M | -19.70M | -11.20M | 335.30M | -26.70M |
| Net income from continuing ops | - | 159.60M | 172.10M | 653.30M | 322.80M |
| Net income applicable to common shares | - | - | - | 649.30M | 320.80M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| Total assets | 3411.00M | 3509.30M | 3579.20M | - | 3611.90M |
| Intangible assets | - | 411.00M | 470.60M | - | 408.60M |
| Other current assets | - | 51.30M | 77.70M | - | 375.80M |
| Total liab | 1208.90M | 1212.40M | 1211.10M | - | 1180.80M |
| Total stockholder equity | 2187.10M | 2282.50M | 2352.50M | - | 2415.60M |
| Other current liab | 13.50M | 140.80M | 134.80M | - | 33.00M |
| Common stock | 15.10M | 15.10M | 15.10M | - | 15.10M |
| Capital stock | - | 15.10M | 15.10M | - | 15.10M |
| Retained earnings | 1567.00M | 1660.10M | 1640.00M | - | 1645.70M |
| Other liab | - | - | - | - | 212.00M |
| Good will | - | 899.60M | 937.90M | - | 844.60M |
| Other assets | - | - | 0.00M | - | 133.50M |
| Cash | 172.80M | 166.80M | 172.50M | - | 320.60M |
| Total current liabilities | 456.60M | 336.50M | 320.20M | - | 487.80M |
| Current deferred revenue | - | - | 9.20M | - | - |
| Net debt | 587.50M | 532.30M | 537.60M | - | 295.20M |
| Short term debt | 162.60M | 48.20M | 50.40M | - | 134.80M |
| Short long term debt | - | 35.00M | 36.70M | - | 121.90M |
| Short long term debt total | 760.30M | 699.10M | 710.10M | - | 615.80M |
| Other stockholder equity | 707.70M | 707.70M | 707.70M | - | 754.80M |
| Property plant equipment | - | - | - | - | 1061.40M |
| Total current assets | 907.10M | 884.20M | 909.40M | - | 1160.40M |
| Net tangible assets | - | - | - | - | 1162.40M |
| Net receivables | 363.80M | 298.20M | 318.00M | - | 375.80M |
| Long term debt | - | 580.20M | 588.40M | - | 401.80M |
| Inventory | 370.50M | 367.90M | 341.20M | - | 464.00M |
| Accounts payable | 280.50M | 126.70M | 125.80M | - | 320.00M |
| Accumulated other comprehensive income | -102.70M | -100.40M | -10.30M | - | - |
| Non currrent assets other | 137.70M | 130.00M | 113.50M | - | 126.60M |
| Non current assets total | 2503.90M | 2625.10M | 2669.80M | - | 2451.50M |
| Capital lease obligations | - | 83.90M | 85.00M | - | 92.10M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -139.10M | -409.80M | 424.60M | -216.20M |
| Change to liabilities | - | - | - | 7.60M | 91.60M |
| Total cashflows from investing activities | -109.80M | -139.10M | -409.80M | 424.60M | -216.20M |
| Net borrowings | - | -9.00M | 125.10M | -399.20M | 23.20M |
| Total cash from financing activities | -152.60M | -182.60M | -52.40M | -552.30M | -112.60M |
| Net income | 62.00M | 279.70M | 171.00M | 515.10M | 438.20M |
| Change in cash | 6.00M | -8.50M | -131.40M | 187.30M | 16.50M |
| Begin period cash flow | 166.80M | 150.20M | 281.60M | 94.30M | 77.80M |
| End period cash flow | 172.80M | 141.70M | 150.20M | 281.60M | 94.30M |
| Total cash from operating activities | 289.50M | 319.40M | 337.50M | 308.20M | 347.70M |
| Issuance of capital stock | - | - | - | - | 0.00M |
| Depreciation | 137.00M | 135.80M | 126.20M | 120.70M | 113.30M |
| Other cashflows from investing activities | 9.80M | 39.30M | -5.20M | -8.30M | 0.40M |
| Dividends paid | 154.90M | 152.20M | 150.70M | 144.40M | 132.50M |
| Change to inventory | -7.30M | -39.30M | 117.80M | -98.10M | -140.90M |
| Change to account receivables | -16.60M | 21.30M | -19.00M | -43.30M | -53.20M |
| Sale purchase of stock | -7.30M | -1.80M | -9.80M | - | -2.40M |
| Other cashflows from financing activities | -19.70M | -19.60M | -17.00M | 206.50M | -0.70M |
| Change to netincome | - | - | - | -293.70M | 50.40M |
| Capital expenditures | 117.70M | 181.80M | 189.00M | 152.40M | 158.70M |
| Change in working capital | -7.70M | 20.90M | 29.10M | -133.80M | -102.50M |
| Stock based compensation | - | 5.00M | -4.20M | -11.00M | 29.10M |
| Other non cash items | 98.20M | -122.00M | 15.40M | -182.80M | -6.20M |
| Free cash flow | 171.80M | 137.60M | 156.80M | 155.80M | 189.00M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CRDA Croda International PLC |
19.00 0.53% |
3628.00 | 68.18 | 16.64 | 2.46 | 1.83 | 2.67 | 17.69 |
| JMAT Johnson Matthey PLC |
4.00 0.16% |
2466.00 | - | 9.44 | 0.29 | 1.53 | 0.36 | 10.76 |
| ELM Elementis PLC |
3.40 1.87% |
185.00 | 19.70 | 15.15 | 1.50 | 1.79 | 2.27 | 9.68 |
| 87FZ AECI Ltd |
-65.09 99.00% |
0.66 | 0.01 | - | 0.02 | - | - | - |
| VCT Victrex plc |
12.00 1.33% |
911.00 | 19.13 | 12.99 | 1.82 | 1.16 | 1.77 | 8.61 |
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen Edward Foots | Group Chief Exec. & Exec. Director | 1969 |
| Mr. Jeremy K. Maiden BA, FCMA | Group Fin. Director & Exec. Director | 1962 |
| Mr. Mark Robinson | Pres of Global Operations | NA |
| Mr. Nicholas Ian Challoner | Group Chief Scientific Officer | NA |
| Mr. David Bishop | Director of Investor Relations | NA |
| Mr. Thomas Michael Brophy | Group Gen. Counsel & Company Sec. | 1974 |
| Mr. Anthony Damien Fitzpatrick | Pres of Performance Technologies, Industrial Chemicals & Corp. Devel. | NA |
| Ms. Tracy Sheedy | Group Human Resource Director | NA |
| Ms. Sandra Elaine Breene | Pres of Regional Delivery | NA |
| Mr. David Cherry | Managing Director of Crop Protection | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.